Market revenue in 2023 | USD 26.9 million |
Market revenue in 2030 | USD 158.9 million |
Growth rate | 28.9% (CAGR from 2023 to 2030) |
Largest segment | Drug optimization & repurposing |
Fastest growing segment | Drug Optimization & Repurposing |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Drug Optimization & Repurposing, Preclinical Testing |
Key market players worldwide | International Business Machines Corp, Exscientia PLC ADR, Alphabet Inc Class A, Benevolent AI, Recursion Pharmaceuticals Inc Class A, Aitia, BioSymetrics, Euretos, Berg, Atomwise, Insitro |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to artificial intelligence in drug discovery market will help companies and investors design strategic landscapes.
Drug optimization & repurposing was the largest segment with a revenue share of 53.53% in 2023. Horizon Databook has segmented the Latin America artificial intelligence in drug discovery market based on drug optimization & repurposing, preclinical testing covering the revenue growth of each sub-segment from 2018 to 2030.
Latin America is expected to be a potential market for AI in healthcare, owing to government readiness for adopting newer technology. According to a survey by International Development Research Centre (IDRC) and Oxford Insights.
The governments of Uruguay, Mexico, and Brazil were ranked among the top 50 countries for readiness to adopt AI. Moreover, integration of AI and machine learning methods into drug discovery pipelines is offering lucrative opportunities to the region by supporting in cutting down cost & time and improving R&D efficiency.
This is anticipated to drive its adoption in the region, which can contribute positively to the overall market growth.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America artificial intelligence in drug discovery market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America artificial intelligence in drug discovery market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account